OXFORD, England--(BUSINESS WIRE)--Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for immune health based on its EpiSwitch 3D genomics ...
Scientists at the University of East Anglia and Oxford Biodynamics have developed a high accuracy blood test to diagnose ...
Jointly led by the University of Oxford and the Manchester University NHS Foundation Trust, the program will put the many tests developed by the life sciences industry to either detect current ...
University of Oxford scientists have created a testing kit that could help confirm COVID-19 within five minutes, which can greatly help in governments' mass testing programs at airports and businesses ...
New adventitious viral agent (AVA) detection test offers rapid, sensitive, and affordable viral screening for biomanufacturers ViruSure, a global leader in pathogen safety testing for ...
Oxford researchers warn that facial recognition lab scores don’t reflect real-world failures, raising risks of bias, wrongful ...
OXFORD, UK - Oxford BioDynamics Plc (AIM: OBD), a biotechnology company, has announced the successful outcomes of a clinical study for its EpiSwitch® Colorectal No-Stool Test (NST), which has been ...
Nanopore sequencing offers a transformational new approach for robust and accurate genetic characterisation of biological materials, enabling the release of novel therapeutics with more certainty and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback